Skip to main content
Moazah Iftikhar on Muck Rack

Moazah Iftikhar

As seen in: Nature, Wiley Online Library
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Moazah

Contact Moazah, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Cancer history and second cancer risk in polycythemia vera and essential thrombocythemia

|
By Giuseppe G. Loscocco, Fnu Aperna, Moazah Iftikhar, Priyansh Faldu, Masooma Rana, Amritpal Singh, Tiziano Barbui, Paola Guglielmelli, Alessandro Vannucchi, Animesh Pardanani, Naseema Gangat Verified, Ayalew Tefferi
| Nature Verified
Abstract Patients with myeloproliferative neoplasms (MPN), including polycythemia vera (PV) and essential thrombocythemia (ET), have an increased risk of second cancers (SC), although determinants of risk remain incompletely defined. We retrospectively analyzed 1968 consecutive patients with PV or ET (median follow-up 11.2 years) to identify predictors of SC. Cumulative incidence functions were estimated using competing-risk methodology, and predictors were assessed using Fine-Gray regression.
Open in Who Shared Issue with article?

The Mutational Landscape in Polycythemia Vera: Phenotype, Genotype, and Prognostic Correlates

|
By Masooma Rana, Moazah Iftikhar, Yamna Jadoon, Maymona G. Abdelmagid
| Wiley Online Library Verified
Conflicts of Interest N.G.: Advisory Board for DISC medicine and Agios. All remaining authors declare no conflicts of interest. Supporting Information Filename Description ajh27717-sup-0001-FigureS1.pptxPowerPoint 2007 presentation , 115.3 KB Supplementary figure S1: Plot of 319 next-generation sequencing (NGS)-annotated patients with polycythemia vera (PV), stratified by timing of NGS.
Open in Who Shared Issue with article?

Cardiac events in newly diagnosed acute myeloid leukaemia during treatment with venetoclax + hypomethylating agents

|
By Isla M. Johnson, Omer S. Karrar, Masooma Rana, Moazah Iftikhar
| Wiley Online Library Verified
CONFLICT OF INTEREST STATEMENT No relevant conflicts to disclose. Supporting Information Filename Description bjh19325-sup-0001-Supplementarytables.docxWord 2007 document , 33.6 KB Table S1. Table S2. REFERENCES 1, , , , , , et al. Azacitidine and venetoclax in previously untreated acute myeloid leukemia. N Engl J Med. 2020; 383(7): 617–629. https://doi.org/10.1056/NEJMoa2012971 2, , , , , .
Open in Who Shared Issue with article?
See all 5 articles